Genetracer Biotech will utilize Fluxion’s IsoFlux circulating tumor cell (CTC) system to provide NGS-based liquid biopsy services for lung and colon cancers.
- EMQN best practice guidelines for the molecular genetic testing passed successfully
- Fluxion Biosciences Appoints Genetracer Biotech of Spain As an Isoflux Liquid Biopsy Certified Service Provider
- Genetracer to explore Mexican market development
- Genetracer Biotech has participated for the second consecutive year as EQA Assessor Scheme for Lung cancer
- Genetracer Biotech has started the exploration of the Ecuadorian market with Phase 1 of the Program Commercial Advisors promoted by ICEX-NEXT